| Amgen (7) |  |
| Biogen idec (8) | |
| Biotechnology company (49) | |
| Amgen (7) | |
| Biogen idec (8) | |
| Biotechnology company (49) | |
This promising compound will soon join the regulatory pipeline of a biotech company called Rxbio Inc,
#Biogen idec Columbia to Conduct Collaborative Genetics Research Biogen idec and Columbia University Medical center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease
The agreement will integrate genomics research conducted at Columbia with Biogen idec understanding of disease mechanisms and pathways,
Biogen idec. e are committed to working with leading institutions such as Columbia to advance basic genetic research and,
The collaboration will enable Biogen idec and Columbia to investigate the genomes of patients showing unusual treatment responses
"Discovered by one of the four private commercial partners in the project, Austrian biotech company Polymun,
and may be suited better for a biotech company, he says. e focus more on the performance of the hydrogels and the underlying molecular mechanisms The National institutes of health,
and will be run by Arthur Levinson, chairman and ex-CEO of biotech company Genentech. Google gave exclusive access to Time magazine for a story on the new venture.
allows Medifocus to partner up with other biotech companies in helping to develop and commercialize targeted thermoactivated/released drugs and gene products which,
Only this year did agricultural biotech company Monsanto introduce its first drought tolerant seed variety Droughtgard. According to the Monsanto website the variety has produced a five-bushel
a biotechnology company based in Richmond, California, to determine whether the company's technique for snipping out targeted genes could be used to delete the CCR5 gene.
October 2010 Biotechnology company Geron doses first patient in world s first clinical trial to test an ES-cell product.
Former heads of the biotech company Geron, based in Menlo Park, California, last week announced an agreement to acquire stem-cell assets including the company s flagship human ES-cell trial, in
Personalis, down the road in Menlo Park, offers sequencing services and interpretation for clinicians and pharmaceutical and biotechnology companies.
The study, conducted by an international ALS consortium that includes scientists and clinicians from Columbia University Medical center (CUMC), Biogen idec,
and Tim Harris, Phd, DSC, Senior vice president, Technology and Translational Sciences, Biogen idec. hese findings demonstrate the power of exome sequencing in the search for rare variants that predispose individuals to disease and in identifying potential
but this is a perfect example of a large, complex project that required many parts, with equal contributions from Biogen idec.
and involved a collaboration between three universities and a biotech company. Both groups designed artificial versions of antibodies, the Y-shaped molecules made by the immune system to target pathogens.
MIT is negotiating an exclusive license agreement with Lyndra, an early-stage biotechnology company developing novel oral drug-delivery systems,
as a biotechnology company with expertise in developing antibodies, they are in a position to act on it
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions.
where anti-Western conspiracy theories about biotech companies have become part of the ruling party ideology. According to Tobaiwa Mudede, a crony of President Robert Mugabe, exual dysfunction is a huge problem in the U s a,
and are already in use as a platform for other applications by biotechnology companies. The University of Chicago team is currently investigating other enzymes that might benefit from monobody technology,
Startup biotechnology company Kallistem in Lyon, France, revealed the breakthrough earlier this year, but now have taken out a patent describing the technique, in tandem with The french National Centre for Scientific research (CNRS).
and the MIT researchers'work was funded by the National Cancer Institute and Massachusetts-based biotech company Kibur Medical.
and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
since Swedish biotech company Atlas Antibodies has shown interest in commercialising our findings, 'says Per-Henrik Edqvist.
and are already in use as a platform for other applications by biotechnology companies. The team is now investigating other enzymes that might benefit from monobody technology,
and different aspects are licensed to a biotechnology company in which Swartz has a founding interest. The approach is in its early stages
He used his research to launch three biotech companies centered on forensic science, fertility assessment and contraception methods.
#Researchers Smash Records with Pig-to-Primate Organ transplants A biotech company is genetically engineering pigs so that their organs might work in people.
The GM pigs are being produced in Blacksburg, Virginia, by Revivicor, a division of the biotechnology company United Therapeutics.
"says Sanjeev Mariathasan, a biologist Genentech, the biotech company behind the study. That's a big problem because drugs that are used normally against staph infections can take over four hours to work far longer than it takes for Staph bacteria to move into new cells,
biotechnology companies have made them as well. Genentech manufactured antibodies based on those the immune system makes to combat staph infections.
a biotechnology company that's working on a similar technique. Now, the researchers have to show that it works against multiple strains of bacteria as well,
Gilead sciences, Inc.;the Howard hughes medical institute; the Department of Dermatology; and the Yale Comprehensive Cancer Center. Publication:
Now, however, several small biotech companies are racing to develop the first approved therapy for ARS,
Biotech company Genencor, which is a division of Danisco, is more than one year into testing the commercial applications for
which is manufactured by the American pharmaceutical company Amgen, have already been submitted to drugs regulators in Europe and the USA.
which is manufactured by the American pharmaceutical company Amgen, have already been submitted to drugs regulators in Europe and the USA.
Aurasense, Inc.,a biotechnology company that licensed the Nanoflare technology from Northwestern University, and EMD-Millipore, another biotech company, have commercialized Nanoflares.
There are now more than 1, 700 commercial forms of Nanoflares sold under the Smartflare? name in more than 230 countries.
However, fewer companies have worked on vaccines and drugs for the MERS virus, according to Reuters. Small biotech companies such as Greffex,
Unfortunately these corporate tax cuts do not provide much-needed capital to small biotech companies because their lack of profits makes tax benefits unredeemable.
Most emerging biotech companies with promising scientific innovation are small, research-intensive and not yet profitable because they do not have approved an FDA product on the market.
and biotech companies to develop better treatments most recently with Shire around rare diseases. These alliances leverage Boston Children research expertise and companiesdevelopment and commercialization capabilities.
and women at biotechnology companies across the world are working hard to advance every day. Read the full Wall street journal article here r
Last week, the U s. Navy signed an agreement with biotech company Biodico to collaborate on developing advanced biofuels and bioenergy refineries throughout the globe for the U s. military.
Aurasense, Inc.,a biotechnology company that licensed the Nanoflare technology from the university, and EMD-Millipore, another biotech company, have commercialized Nanoflares.
There are now more than 1, 700 commercial forms of Nanoflares sold under the Smartflare name in more than 230 countries.
"The acquisition of NPS Pharma is a significant step in advancing Shire's strategy to become a leading biotechnology company, Shire CEO Flemming Ornskov, M d,
Amgen markets cinacalcet HCL as Sensipar in the U s. and as Mimpara in the EU;
Express Scriptsindependent Pharmacy & Therapeutics Committee concluded that Viekira Pak was at least clinically equivalent to two Gilead sciences drugs, Harvoni (ledipasvir and sofosbuvir) and Sovaldi (sofosbuvir.
Representatives of two other top-selling cancer drug developers, Celgene and Amgen, at deadline had responded not to GEN queries on indication pricing
. a biotech company associated with Cedars-Sinai. The study was supported by NIH grants U01 CA151815, R01 CA136841, R01 CA188743,
Aurasense, Inc.,a biotechnology company that licensed the Nanoflare technology from Northwestern University, and EMD-Millipore, another biotech company, have commercialized Nanoflares.
There are now more than 1, 700 commercial forms of Nanoflares sold under the Smartflare? name in more than 230 countries.
MIT is negotiating an exclusive license agreement with Lyndra, an early-stage biotechnology company developing novel oral drug-delivery systems, for this and other related technologies.
The british biotech company Oxitec has been developing a unique form of pest control for over a decade.
Amgen, is to get approval from the FDA and the European Medicines Agency. The drug is administered once every two weeks for up to 18 months
A new trial will commence shortly using the Celgene CC-115 DNA-PKCS inhibitor. This new trial will be for patients advancing on standard of care therapies,
Independently, the biotechnology company Prothena Corporation plc also discovered complementary data regarding MCAM, which led to an ongoing collaboration between the CRCHUM and Prothena.
The trial was funded by the manufacturer of T-VEC, Amgen, and is published in the Journal of Clinical Oncology.
Chesney and his team, working with the pharmaceutical company Amgen, are taking the success of their trials a step further combining T-VEC with the immune checkpoint inhibitor ipilimumab into a treatment regimen.
Based on these preclinical data, the HIV-1 version of this vaccine regimen is now being evaluated in an ongoing international clinical study sponsored by Crucell Holland BV
MIT is negotiating an exclusive license agreement with Lyndra, an early-stage biotechnology company developing novel oral drug-delivery systems,
#After Celgene Deal, Juno Revs Armored CAR For Ovarian Cancer Trial Juno Therapeutics has built remarkable momentumncluding last week much-dissected $1 billion deal with Celgenepon
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011